DoD Prostate Cancer, Translational Science Award — Defense Health Agency Contracting Activity - DHACA funding opportunity
Defense Health Agency Contracting Activity - DHACA · Federal agency

DoD Prostate Cancer, Translational Science Award

The FY23 PCRP Translational Science Award mechanism supports advanced translational research that will foster transformation of promising ideas in prostate cancer into clinical applications, ultimately providing a soluti...

68
match
Deadline 1031 days ago Location Alabama Type grant Level Federal Closed posted Apr 26, 2023
✦ AI Summary
  • Who can apply: Federal-level applicants (see eligibility for details).
  • Funding amount: total funding pool ~$7,200,000.
  • Next deadline: August 24, 2023.
  • Issued by: Defense Health Agency Contracting Activity - DHACA.
How was this generated?

The “key facts” mode pulls structured fields directly from the official source posting (amount, deadline, eligibility tags). The AI mode adds a short plain-English narrative on top, generated from the same source. Always verify with the agency before applying.

AI-generated. Always verify with the official source.

Deadline
1031 days ago
Aug 24, 2023
Total pool
$7.2M

About this opportunity

The FY23 PCRP Translational Science Award mechanism supports advanced translational research that will foster transformation of promising ideas in prostate cancer into clinical applications, ultimately providing a solution to one or more of the FY23 PCRP Overarching Challenges. Translational research may be defined as an integration of basic science and clinical observations. Observations that drive a research idea may originate from a laboratory discovery, population-based studies, or a clinician’s firsthand knowledge of patient care. Principal Investigators (PIs) should not view translational research as a one-way continuum from bench to bedside but can include a reciprocal flow of ideas and information between basic science and clinical science (bench to bedside and/or bedside to bench).New for FY23! The intent of the Translational Science Award is expanded for FY23 to include support for implementation science studies that will bridge the gap between clinical research and real-world implementation. Even after interventions have been successfully evaluated in their intended populations, the development of knowledge to support their broader dissemination and implementation has often remained outside the scope, limiting the impact on the intended patient population(s). As part of the TSA, implementation science studies are expected to bridge the gap between policy by building a knowledge base on how interventions, clinical practices/guidelines, tools, and policies can be deployed to targeted populations at the appropriate time and point of need. An implementation science study is defined as the scientific study of the use of strategies to adopt and integrate evidence-based health interventions into clinical and community settings in order to improve patient outcomes and benefit population health.This mechanism is intended to fund a broad range of translational studies including, but not limited to, the following:• Advanced preclinical studies aimed at translating results from animal studies to applications with human samples/cohorts (the Translational Science Award is not intended to support initial mechanistic studies of a new target)• Late-stage preclinical work leading to/preparing for a clinical trial, an Investigational New Drug application submission• Correlative studies that are associated with an open/ongoing or completed clinical trial, projects that utilize biospecimens from clinical trials to improve clinical management of prostate cancer and/or define new areas of research• Projects that develop endpoints for clinical trials• Analysis of existing clinical tools to inform clinical practice and/or maximize patient-relevant outcomes• Small-scale clinical trials with implementation science focus• Comparative effectiveness research establishing the benefits and harms of emerging or standard-of-care interventions and strategies to monitor health conditions in real-world settings• Development and evaluation of strategies to overcome barriers to the sustainability of evidence-based guidelines.Preliminary data to support the scientific rationale and feasibility of the research approaches are required. The inclusion of additional preliminary data to support the clinical relevance of the idea is strongly encouraged.Applications should carefully consider study sample size to ensure that the study results will be able to support valid conclusions and further translation toward clinical application. It is the applicant’s responsibility to demonstrate access to the required resources or populations necessary for the study and to provide sufficient evidence that the sample size is appropriate to meet the objectives of the study.

Funding agency

Tags

Want help applying?

Our specialists will check your eligibility, prepare the application, and walk you through every step — for free. Create a free account →

Who can apply

Eligibility details aren't on file yet — check the agency source link in the Documents tab for the latest rules.

Geographic eligibility

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming
  • District of Columbia

How to apply

We don't have application instructions on file yet — head straight to the official source.

Apply on agency site
Tip from our team:

Read the agency's eligibility checklist before you start — it's almost always shorter than the full NOFO and will tell you in 90 seconds whether to keep going.

Need help getting in touch with the right agency contact?

Create a free account and our specialists will guide you through the application end-to-end.

Source documents

View on agency site
Canonical NOFO, application packet, and forms
No supplemental documents yet.

Direct downloads (NOFO PDFs, application forms, FAQs) will appear here once our team attaches them. For now, the agency site has the canonical packet.

Citation details

Source systemgrants.gov
Source ID347773
PostedApr 26, 2023

Frequently asked questions

No FAQs yet.

Have a question about this fund? Sign in to open a ticket about this fund.